Advertisement
Screener

HOLOGIC INC Forms 3, 4 and 5: Stock Options, 2018

HOLOGIC INC Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 31 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2018-11-30: Reporting owner COHN BENJAMIN JORDAN; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
  • 2018-11-28: Reporting owner Stamoulis Christiana; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
  • 2018-11-21: Reporting owner HANTSON LUDWIG; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2018-11-12: Reporting owner West Thomas A.; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2018-11-30COHN BENJAMIN JORDAN
Officer (Principal Accounting Officer)
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−10,000
6,830 owned after
$19.86
exercise price
2018-12-04
2018-11-28Stamoulis Christiana
Director
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−13,257
0 owned after
$17.51
exercise price
2018-11-30
2018-11-21HANTSON LUDWIG
Director
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+2,012
2,012 owned after
$41.54
exercise price
2018-11-26
2018-11-12West Thomas A.
Officer (Div President & GM, Diagnostic)
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+20,491
20,491 owned after
$40.97
exercise price
2018-11-14
2018-11-12Valenti Peter J. III
Officer (Division Pres., Breast Health)
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+26,080
26,080 owned after
$40.97
exercise price
2018-11-14
2018-11-12MACMILLAN STEPHEN P
Director, Officer (Chairman, President and CEO)
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+151,071
151,071 owned after
$40.97
exercise price
2018-11-14
2018-11-12Griffin John M.
Officer (General Counsel)
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+27,943
27,943 owned after
$40.97
exercise price
2018-11-14
2018-11-12COHN BENJAMIN JORDAN
Officer (Principal Accounting Officer)
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+9,128
9,128 owned after
$40.97
exercise price
2018-11-14
2018-11-12Bebo Allison P
Officer (SVP, Human Resources)
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+13,971
13,971 owned after
$40.97
exercise price
2018-11-14
2018-11-12Oberton Karleen Marie
Officer (Chief Financial Officer)
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+26,080
26,080 owned after
$40.97
exercise price
2018-11-14
2018-10-02Stamoulis Christiana
Director
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−30,967
0 owned after
$15.29
exercise price
2018-10-04
2018-09-19COHN BENJAMIN JORDAN
Officer (Principal Accounting Officer)
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−3,437
0 owned after
$17.09
exercise price
2018-09-21
2018-09-17CRAWFORD SALLY
Director
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−13,257
0 owned after
$17.51
exercise price
2018-09-19
2018-08-06
holding as of filing
COHN BENJAMIN JORDAN
Officer (Principal Accounting Officer)
3Non-qualified Stock Option (Right to Buy)
Derivative · Direct
Holding$17.09
exercise price
2018-08-06
2018-08-06
holding as of filing
COHN BENJAMIN JORDAN
Officer (Principal Accounting Officer)
3Non-qualified Stock Option (Right to Buy)
Derivative · Direct
Holding$19.86
exercise price
2018-08-06
2018-08-06
holding as of filing
COHN BENJAMIN JORDAN
Officer (Principal Accounting Officer)
3Non-qualified Stock Option (Right to Buy)
Derivative · Direct
Holding$21.45
exercise price
2018-08-06
2018-08-06
holding as of filing
COHN BENJAMIN JORDAN
Officer (Principal Accounting Officer)
3Non-qualified Stock Option (Right to Buy)
Derivative · Direct
Holding$23.82
exercise price
2018-08-06
2018-08-06
holding as of filing
COHN BENJAMIN JORDAN
Officer (Principal Accounting Officer)
3Non-qualified Stock Option (Right to Buy)
Derivative · Direct
Holding$26.21
exercise price
2018-08-06
2018-08-06
holding as of filing
COHN BENJAMIN JORDAN
Officer (Principal Accounting Officer)
3Non-qualified Stock Option (Right to Buy)
Derivative · Direct
Holding$39.96
exercise price
2018-08-06
2018-08-06
holding as of filing
COHN BENJAMIN JORDAN
Officer (Principal Accounting Officer)
3Non-qualified Stock Option (Right to Buy)
Derivative · Direct
Holding$37.64
exercise price
2018-08-06
2018-08-06
holding as of filing
COHN BENJAMIN JORDAN
Officer (Principal Accounting Officer)
3Non-qualified Stock Option (Right to Buy)
Derivative · Direct
Holding$40.85
exercise price
2018-08-06
2018-05-29Valenti Peter J. III
Officer (Division Pres., Breast Health)
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−7,766
7,766 owned after
$23.82
exercise price
2018-05-30
2018-05-02Oberton Karleen Marie
Officer (Corp. VP & Chief Acctg Officer)
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−4,202
0 owned after
$17.09
exercise price
2018-05-04
2018-05-02Oberton Karleen Marie
Officer (Corp. VP & Chief Acctg Officer)
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−7,994
0 owned after
$19.86
exercise price
2018-05-04
2018-03-14Wendell Amy McBride
Director
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+7,551
7,551 owned after
$38.44
exercise price
2018-03-16
2018-03-14Stamoulis Christiana
Director
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+7,551
7,551 owned after
$38.44
exercise price
2018-03-16
2018-03-14Nawana Namal
Director
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+7,551
7,551 owned after
$38.44
exercise price
2018-03-16
2018-03-14GARRETT SCOTT T
Director
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+7,551
7,551 owned after
$38.44
exercise price
2018-03-16
2018-03-14Dockendorff Charles J
Director
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+7,551
7,551 owned after
$38.44
exercise price
2018-03-16
2018-03-14CRAWFORD SALLY
Director
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+10,661
10,661 owned after
$38.44
exercise price
2018-03-16
2018-01-11Nawana Namal
Director
4Non-qualified Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,113
1,113 owned after
$43.55
exercise price
2018-01-16